Le Lézard
Classified in: Health
Subjects: SVY, AVO

Do No Harm Releases New Report: "Racial Concordance in Medicine: The Return of Segregation"


RICHMOND, Va., Dec. 19, 2023 /PRNewswire/ -- Today, Do No Harm released a new report on racial concordance in medicine entitled "The Return of Segregation." This report debunks the narrative pushed by medical organizations and political leaders that matching the races of physicians and patients leads to better healthcare outcomes.

"Healthcare and media organizations continue to push racial concordance despite the weight of evidence against it," said report author and Do No Harm Director of Research Ian Kingsbury. "These groups are playing a dangerous game by putting their politics over scientific evidence and cherry-picking preferred studies to reach their political goals. We hope our report puts to rest the fashionable but dangerous idea of racial segregation in medicine."

"The research that claims to find evidence of the benefits of racial concordance in healthcare is generally of low quality," said report co-author and Do No Harm Senior Fellow Jay Greene. "Even the studies that appear in higher-status journals have obvious and severe defects that prevent them from being offered as support for racial concordance. The fact that such low-quality research appears in top journals says more about the politicization of research than it does about racial concordance."

"We all want to see the elimination of healthcare disparities, but without solid proof that racial concordance would benefit patients we needlessly racialize an aspect of American life and divide American communities," said Do No Harm Chairman Dr. Stanley Goldfarb. "The same divisive identity politics pushed by supporters of 'diversity, equity and inclusion' is being used as the basis for racial concordance."

Click here to read the full report. 

Top Takeaways

Established in April 2022, Do No Harm has more than 6,000 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and in 14 countries. 

SOURCE Do No Harm


These press releases may also interest you

at 04:00
Calibre Scientific is pleased to announce the acquisition of Camlab Limited ("Camlab" or the "Company"), a UK-based supplier of scientific equipment, chemicals, consumables, labware, and other laboratory supplies and services to customers in the...

at 04:00
Hurom, a pioneer in the development of the slow juicer and a leader in the global market, is stepping up efforts to safeguard patent rights worldwide to protect its proprietary technology and contribute to a healthy industry ecosystem. Despite...

at 03:46
Allied Market Research published a report titled, "Biosimilar Testing and Development Services Market Share, Size, Competitive Landscape and Trend Analysis Report by Type, by End User: Global Opportunity Analysis and...

at 03:46
Foresee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today that it will actively participate in and present two posters at the 2024 American Thoracic Society (ATS) International Conference, which will be held in San Diego, CA, from May 17 to...

at 03:31
In recent years, the rapid development of artificial intelligence has introduced new possibilities across numerous scientific disciplines. As an AI for Science pioneer, DP Technology is continually collaborating with partners to explore the...

at 03:01
'Textbook of Tinnitus' is a comprehensive textbook that describes tinnitus, how it is caused, and state-of-the art interventions such as Lenire.Top-ranked tinnitus expert authors of the Textbook of Tinnitus state that Lenire's clinical trial results...



News published on and distributed by: